jnj

  1. Class Action Lawsuit against J&J for DEI related Discrimination and Harrassment

    Please message me privately if you believe you have grounds to participate in this Class Action lawsuit against J&J, or if you have any information that could help, for which you will be compensated. If you are an attorney, please note that a law firm has already been retained. Thank you.
  2. Was Auris sale to JNJ the biggest swindle in the history of business?

    Five BILLION dollars. With a "B". For taking lung biopsies, the DRG payment to the hospital is what... $500??? Intuitive Ion system is crushing them, all day, ERR day. And it does more than lung biopsies. Now JNJ fired the entire town of San Carlos, and emptied the building. Shareholder...
  3. Sales Force Size for Neostrata??

    Does anyone know how many reps there are for Neostrata?
  4. STEM jobs without STEM training or education

    I'm flabbergasted. Why would any company, let alone JNJ, promote the hiring of people with no formal STEM-related training to seek STEM jobs. Two questions: 1. Aren't there enough STEM grad to do this work (the answer is yes!!!!!) and 2. Are they trying to set these people up for failure or are...
  5. A visual treat of JNJ Q1 2020 earnings

    Johnson & Johnson (JNJ) reported that its first-quarter 2020 earnings and revenue came in above the analysts’ expectations citing product sales as well as lower costs and expenses. Region-wise, sales were better in the US than international. The Consumer and Pharmaceutical segments experienced...
  6. JNJ reports strong Q3 and better outlook

    Earnings of Johnson & Johnson increased and topped the Street view in Q3 helped by a 2% growth in sales. Encouraged by the positive outcome, the management revised up its full-year earnings and sales outlook. The company’s stock gained following the announcement. Read More
  7. JNH Q1 2019 earnings slide on flat revenue growth

    JNJ kicked off pharma earnings as it posted its first-quarter 2019 earnings on Tuesday, April 16, before the opening bell. Reported revenue for the quarter barely changed — inching just 0.1% higher — at $20 billion, while net earnings slipped 14% to $3.7 billion. On a diluted basis, earnings...
  8. J&J kicks off pharma earnings: posts stellar sales in pharma segment

    JNJ saw sales inch 1% up to $20.4 billion in the fourth quarter of 2018. Operational sales results rose 3.3%. Domestic sales increased 1.5%, while international sales grew 0.4%. Adjusted earnings grew about 13% to $5.4 billion or $1.97 per diluted share While both Medical and Consumer segments...
  9. Typical hours, income, etc.

    I am considering a rep job with JNJ Depuy Ortho and I had some generic questions. Typical hours a week for a rep position? Expected income on year 1? Expected income on year 5? General pros/cons to the job? Company car/gas card? How often is call taken or is that area specific? I know...
  10. Johnson & Johnson beats Q2 expectations (Infographic)

    Healthcare giant Johnson & Johnson (JNJ) reported a beat on both the top and bottom line expectations as it posted its Q2 2018 earnings. This was aided by a double-digit growth in Pharmaceutical business and the accelerating sales momentum in the Medical Devices business...
  11. JNJ's AIDS vaccine could soon be a reality

    At an AIDS conference in Paris on July 24, 2017, Johnson&Johnson announced updates on its developmental AIDS drug. And guess what, it's good news!
  12. JNJ close to AIDS vaccine

    At the 9th IAS Conference on HIV Science, JNJ announced results of its clinical trials on AIDS vaccine. And guess what? It's good news. This is huge!
  13. Ortho Neutrogena

    How is it this company has escaped Cafe Pharma boards? Surely there is plenty there to talk about.